OOIR: Observatory of International Research

Papers

(The H4-Index of Depression and Anxiety is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
COVID stress syndrome: Concept, structure, and correlates	452
U.S. Census Bureau‐assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID‐19 pandemic	281
Exposure to COVID‐19 pandemic stress: Associations with depression and anxiety in emerging adults in the United States	182
The psychiatric sequelae of the COVID‐19 pandemic in adolescents, adults, and health care workers	147
Anxiety, pandemic‐related stress and resilience among physicians during the COVID‐19 pandemic	137
Living in the midst of fear: Depressive symptomatology among US adults during the COVID‐19 pandemic	108
Unraveling the comorbidity of depression and anxiety in a large inpatient sample: Network analysis to examine bridge symptoms	100
Moral distress in frontline healthcare workers in the initial epicenter of the COVID‐19 pandemic in the United States: Relationship to PTSD symptoms, burnout, and psychosocial functioning	84
Suicidal ideation and thoughts of self‐harm during the COVID‐19 pandemic: The role of COVID‐19‐related stress, social isolation, and financial strain	79
Co‐morbidity between mood and anxiety disorders: A systematic review and meta‐analysis	71
The impact of coronavirus (COVID‐19) in the diagnosis and treatment of obsessive‐compulsive disorder	69
Thirty‐day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID‐19 outbreak	66
Reduced hippocampal and amygdala volume as a mechanism underlying stress sensitization to depression following childhood trauma	65
Internet addiction among college students in a Chinese population: Prevalence, correlates, and its relationship with suicide attempts	61
COVID‐19 and Anxiety and Depression in 2020	59
The association between witnessing patient death and mental health outcomes in frontline COVID‐19 healthcare workers	56
The effect of vitamin D supplement on negative emotions: A systematic review and meta‐analysis	54
Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta‐analysis	48
A health care workers mental health crisis line in the age of COVID‐19	47
Detecting suicidal thoughts: The power of ecological momentary assessment	46
Development and validation of a machine learning‐based postpartum depression prediction model: A nationwide cohort study	40
Association of job loss, income loss, and financial burden with adverse mental health outcomes during coronavirus disease 2019 pandemic in Thailand: A nationwide cross‐sectional study	38
Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment	37
Healthcare use and costs in adult cancer patients with anxiety and depression	36
Does COVID‐19 count?: Defining Criterion A trauma for diagnosing PTSD during a global crisis	36

Three steps to flatten the mental health need curve amid the COVID‐19 pandemic	36
Moral injury and suicidal behavior among US combat veterans: Results from the 2019–2020 National Health and Resilience in Veterans Study	36
Acute effects of cannabinoids on symptoms of obsessive‐compulsive disorder: A human laboratory study	33
Cognitive behavioral therapy for misophonia: A randomized clinical trial	33
Efficacy of digital cognitive behavioral therapy for moderate‐to‐severe symptoms of generalized anxiety disorder: A randomized controlled trial	32
Network analysis of PTSD and depressive symptoms in 158,139 treatment‐seeking veterans with PTSD	30
Automated voice biomarkers for depression symptoms using an online cross‐sectional data collection initiative	30
Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder	30